Kanjinti 150 mg and 420 mg
*Company:
Amgen Ireland LtdStatus:
NewLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 26 September 2025
File name
en_kanjinti_approved_pil_renewal.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
PIL reinstated
Product discontinued
No updates
Updated on 26 September 2025
File name
en_kanjinti_approved_spc_renewal.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
No changes - reinstated smpc that was accidentally retired
Product is discontinued
Amgen Ireland Ltd
Address:
21 Northwood Court, Santry, Dublin D09 TX31, Ireland, 216 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0WA, UKMedical Information E-mail:
gbinfoline@amgen.comTelephone:
+44 (0)1223 420 305Website:
https://www.amgen.co.ukMedical Information Direct Line:
+44 (0)1223 436 441/Freephone: 1800 535160Customer Care direct line:
+44 (0)1223 436441/Freephone: 1800 535160